Iron chelation therapy in patients with low‐ to intermediate‐risk myelodysplastic syndrome: A systematic review and meta‐analysis
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 2022
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Chelation Therapy (MeSH)
- Humans (MeSH)
- Immunology (Science Metrix)
- Iron (MeSH)
- Iron Chelating Agents (MeSH)
- Iron Overload (MeSH)
- Myelodysplastic Syndromes (MeSH)
published in
- British Journal of Haematology Journal